North America Electronic Clinical Outcome Assessment (eCOA) Market Growth, Future Outlook
North America Electronic Clinical Outcome Assessment (eCOA) Market Size- By Product, By Approach, By Platform, By Delivery Mode, By End User- Regional Outlook, Competitive Strategies and Segment Forecast to 2032
| Published: Feb-2023 | Report ID: HLCA2311 | Pages: 1 - 151 | Formats*: |
| Category : Healthcare | |||
North America Electronic Clinical Outcome Assessment (eCOA) Market Overview
According to SPER Market Research, the North America Electronic Clinical Outcome Assessment (eCOA) Market is estimated to reach USD 942.94 billion by 2032 with a CAGR of 17.13%.
Clinical trial outcomes data are electronically collected using the Electronic Clinical Outcome Assessment (eCOA) approach. eCOA enables trial participants, doctors, and caregivers to directly report data regarding healthcare outcomes using technology like mobile phones, tablets, and the internet. An increase in clinical trials is urgently required to boost compliance, efficiently acquire, and manage clinical data. Market expansion is predicted to be fuelled by the desire to save expenses and a rise in R&D activity. New methods for developing medications are gradually moving away from paper-based processes in favour of electronic data acquisition to lower overall costs. When data are collected using electronic clinical outcome assessment platforms, the quality of the data is increased, data collection procedures are standardized, and data analysis is provided to users at a significant benefit. All of the problems of paper-based records are eliminated by electronic data collecting and analysis systems, which also increase patient compliance.
Additionally, they eliminate the possibility of data fluctuation and reduce the expense of site monitoring. In the upcoming years, product demand is anticipated to be driven by the benefits of adopting electronic clinical outcome assessments that were just described. Thus, it is becoming more common to evaluate the effectiveness of various chronic illness medications using clinical outcome evaluations (COAs). The regulatory approval of medications has frequently depended on these. Its expansion will also be aided by the installation of a variety of services.
-00728307022023.jpg)
Impact of COVID-19 on the North America Electronic Clinical Outcome Assessment (eCOA) Market
The COVID-19 pandemic made it difficult to manage the clinical study. In order to solve these issues and ensure the continuation of clinical research activities, market participants undertook a number of measures, including the use of eClinical technology. Due to the outbreak, clinical studies were converted to digital format. A rising number of sponsors, biopharma companies, medical device companies, and contract research organizations (CROs) have started using eClinical platforms to acquire, organize, and extract meaningful insights from data in a remote, economical manner. Remote access to patient data is possible with the use of electronic clinical outcome evaluation (eCOA).
-00832427022023.jpg)
Scope of the Report:
| Report Metric | Details |
| Market size available for years | 2019-2032 |
| Base year considered | 2021 |
| Forecast period | 2022-2032 |
| Segments covered | By Product, By Approach, By Platform, By Delivery Mode, By End User |
| Regions covered | Canada, Mexico, U.S. |
| Companies Covered | Clario, Climedo Health GmbH, ClinCapture, Cloudbyz, CRF Health, eClinical Solutions, IBM Corporation, IQVIA, Medidata Solutions, Inc., OmniComm Systems, Inc., Oracle Corporation, Paraxel International Corporation, Signant Health, TransPerfect |
North America Electronic Clinical Outcome Assessment (eCOA) Market Segmentation:
1. By Product:
- Cloud Based Solutions
- On-Premise Solutions
- Web Based Solutions
2. By Approach
- Clinician- reported Outcome
- Observer- reported Outcome
- Patient-reported Outcome
- Performance Outcome
3. By Platform
- Consulting Service Companies
- Contract Research Organizations
- Hospitals and Clinical Laboratories
- Medical Device Manufacturers
- Pharmaceutical and Biopharmaceutical Companies
- Research and Academia
- Others
4. By Delivery Mode:
- Cloud-hosted
- Web-hosted
5. By End User:
- Commercial Service Providers
- Hospitals and Transplant Centers
- Research Laboratories and Academia Institutions
6. By Region:
- Canada
- Mexico
- U.S.
Key Topics Covered in the Report:
- Size of North America Electronic Clinical Outcome Assessment (eCOA) Market (FY’2019-FY’2032)
- Overview of North America Electronic Clinical Outcome Assessment (eCOA) Market
- Segmentation of North America Electronic Clinical Outcome Assessment (eCOA) Market By Product (Cloud Based Solutions, On-Premise Solutions, Web Based Solutions)
- Segmentation of North America Electronic Clinical Outcome Assessment (eCOA) Market By Approach (Clinician- reported Outcome, Observer- reported Outcome, Patient-reported Outcome, Performance Outcome)
- Segmentation of North America Electronic Clinical Outcome Assessment (eCOA) Market By Platform (Consulting Service Companies, Contract Research Organizations, Hospitals and Clinical Laboratories, Medical Device Manufacturers, Pharmaceutical and Biopharmaceutical Companies, Research and Academia, Others)
- Segmentation of North America Electronic Clinical Outcome Assessment (eCOA) Market By Delivery Mode (Cloud-hosted, Web-hosted)
- Segmentation of North America Electronic Clinical Outcome Assessment (eCOA) Market By End User (Commercial Service Provider, Hospitals and Transplant Centers, Research Laboratories and Academia Institutions)
- Statistical Snap of North America Electronic Clinical Outcome Assessment (eCOA) Market
- Growth Analysis of North America Electronic Clinical Outcome Assessment (eCOA) Market
- Problems and Challenges in North America Electronic Clinical Outcome Assessment (eCOA) Market
- Competitive Landscape in the North America Electronic Clinical Outcome Assessment (eCOA) Market
- Impact of COVID-19 and Demonetization on North America Electronic Clinical Outcome Assessment (eCOA) Market
- Details on Recent Investment in North America Electronic Clinical Outcome Assessment (eCOA) Market
- Competitive Analysis of North America Electronic Clinical Outcome Assessment (eCOA) Market
- Major Players in the North America Electronic Clinical Outcome Assessment (eCOA) Market
- SWOT Analysis of North America Electronic Clinical Outcome Assessment (eCOA) Market
- North America Electronic Clinical Outcome Assessment (eCOA) Market Future Outlook and Projections (FY’2019-FY’2032)
- Recommendations from Analyst
1. Introduction
1.1. Scope of the report1.2. Market segment analysis
2. Research Methodology
2.1 Research data source2.1.1 Secondary data2.1.2 Primary data2.1.3 SPER’s internal database2.1.4 Premium insight from KOL’s2.2 Market size estimation2.2.1 Top-down and Bottom-up approach2.3 Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis4.1.1 Drivers4.1.2 Restraints4.1.3 Opportunities4.1.4 Challenges
4.2. COVID-19 Impacts of the North America Electronic Clinical Outcome Assessment (eCOA) Market
5. Market variables and outlook
5.1. SWOT analysis5.1.1 Strengths5.1.2 Weaknesses5.1.3 Opportunities5.1.4 Threats5.2. PESTEL analysis5.2.1 Political landscape5.2.2 Economic landscape5.2.3 Social landscape5.2.4 Technological landscape5.2.5 Environmental landscape5.2.6 Legal landscape5.3. PORTER’S five forces analysis5.3.1 Bargaining power of suppliers5.3.2 Bargaining power of Buyers5.3.3 Threat of Substitute5.3.4 Threat of new entrant5.3.5 Competitive rivalry5.4. Heat map analysis
6. Competitive Landscape
6.1 North America Electronic Clinical Outcome Assessment (eCOA) Manufacturing Base Distribution, Sales Area, Product Type6.2 Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in North America Electronic Clinical Outcome Assessment (eCOA) Market
7. North America Electronic Clinical Outcome Assessment (eCOA) Market, By Product, 2019-2032 (USD Million)
7.1 Cloud Based Solutions7.2 On-Premise Solutions7.3 Web Based Solutions
8. North America Electronic Clinical Outcome Assessment (eCOA) Market, By Approach, 2019-2032 (USD Million)
8.1 Clinician- reported Outcome8.2 Observer- reported Outcome8.3 Patient-reported Outcome
8.4 Performance Outcome
9. North America Electronic Clinical Outcome Assessment (eCOA) Market, By Platform, 2019-2032 (USD Million)
9.1 Consulting Service Companies9.2 Contract Research Organizations9.3 Hospitals and Clinical Laboratories9.4 Medical Device Manufacturers9.5 Pharmaceutical and Biopharmaceutical Companies9.6 Research and Academia9.7 Others
10. North America Electronic Clinical Outcome Assessment (eCOA) Market, By Delivery Mode, 2019-2032 (USD Million)
10.1 Cloud-hosted10.2 Web-hosted
11. North America Electronic Clinical Outcome Assessment (eCOA) Market, By End User, 2019-2032 (USD Million)
11.1 Commercial Service Providers11.2 Hospitals and Transplant Centers11.3 Research Laboratories and Academia Institutions
12. North America Electronic Clinical Outcome Assessment (eCOA) Market, By Region, 2019-2032 (USD Million)
12.1 North America Electronic Clinical Outcome Assessment (eCOA) Size and Market Share by Region (2019-2025)12.2 North America Electronic Clinical Outcome Assessment (eCOA) Size and Market Share by Region (2026-2032)12.3 Canada12.4 Mexico12.5 U.S.
13. Company Profiles
13.1 Clario13.1.1 Company details13.1.2 Financial outlook13.1.3 Product summary13.1.4 Recent developments13.2 Climedo Health GmbH13.2.1 Company details13.2.2 Financial outlook13.2.3 Product summary13.2.4 Recent developments13.3 ClinCapture13.3.1 Company details13.3.2 Financial outlook13.3.3 Product summary13.3.4 Recent developments13.4 Cloudbyz13.4.1 Company details13.4.2 Financial outlook13.4.3 Product summary13.4.4 Recent developments13.5 CRF Health13.5.1 Company details13.5.2 Financial outlook13.5.3 Product summary13.5.4 Recent developments13.6 eClinical Solutions13.6.1 Company details13.6.2 Financial outlook13.6.3 Product summary13.6.4 Recent developments13.7 IBM Corporation13.7.1 Company details13.7.2 Financial outlook13.7.3 Product summary13.7.4 Recent developments13.8 IQVIA13.8.1 Company details13.8.2 Financial outlook13.8.3 Product summary13.8.4 Recent developments13.9 Medidata Solutions, Inc.13.9.1 Company details13.9.2 Financial outlook13.9.3 Product summary13.9.4 Recent developments13.10 OmniComm Systems, Inc.13.10.1 Company details13.10.2 Financial outlook13.10.3 Product summary13.10.4 Recent developments13.11 Oracle Corporation13.11.1 Company details13.11.2 Financial outlook13.11.3 Product summary13.11.4 Recent developments13.12 Paraxel International Corporation13.12.1 Company details13.12.2 Financial outlook13.12.3 Product summary13.12.4 Recent developments13.13 Signant Health13.13.1 Company details13.13.2 Financial outlook13.13.3 Product summary13.13.4 Recent developments13.14 TransPerfect13.14.1 Company details13.14.2 Financial outlook13.14.3 Product summary13.14.4 Recent developments
14. List of Abbreviations
15. Reference Links
16. Conclusion
17. Research Scope
SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.
The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.
Frequently Asked Questions About This Report
North America Electronic Clinical Outcome Assessment (eCOA) Market is projected to reach USD 942.94 billion by 2032, growing at a CAGR of 17.13% during the forecast period.
North America Electronic Clinical Outcome Assessment (eCOA) Market grew in market size from 2021. The Market is expected to reach USD 942.94 billion by 2032, at a CAGR of 17.13% during the forecast period.
North America Electronic Clinical Outcome Assessment (eCOA) Market CAGR of 17.13% during the forecast period.
You can get the sample pages by clicking the link - Click Here
North America Electronic Clinical Outcome Assessment (eCOA) Market size is USD 942.94 billion from 2022 to 2032.
North America Electronic Clinical Outcome Assessment (eCOA) Market Segment is Covered By Product, By Approach, By Platform, By Delivery Mode, By End User
The North America region is anticipated to have the highest market share in North America Electronic Clinical Outcome Assessment (eCOA) Market.
The key players in the market include Companies Covered Clario, Climedo Health GmbH, ClinCapture, Cloudbyz, CRF Health, eClinical Solutions, IBM Corporation, IQVIA, Medidata Solutions, Inc., OmniComm Systems, Inc., Oracle Corporation, Paraxel International Corporation, Signant Health, TransPerfect
All of the problems of paper-based records are eliminated by electronic data collecting and analysis systems, which also increase patient compliance.
PLACE AN ORDER
Year End Discount
Sample Report
Pre-Purchase Inquiry
NEED CUSTOMIZATION?
Request CustomizationCALL OR EMAIL US
100% Secure Payment
Related Reports
Have a glance of the Report
Our Global Clients
Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.
